Leukemia cells and the cytokine network

Proceedings of the Society for Experimental Biology and Medicine

Volumn 219, Issue 1, 1998, Pages 8-27

  Moqattash, S ^a   Lutton, J D ^b  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

APOPTOSIS; CANCER CELL; CANCER GROWTH; CELL DIFFERENTIATION; CELL VIABILITY; HUMAN; HUMAN CELL; LEUKEMIA; SHORT SURVEY;

EID: 0031713306     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-219-44311     Document Type: Short Survey

References (233)

1. Sachs L. The control of hematopoiesis and leukemia: From basic biology to the clinic. Proc Natl Acad Sci U S A 93:4742-4749, 1995.
2. Cross M, Dexter TM. Growth factors in development, transformation, and tumorigenesis. Cell 64:271-285, 1991.
3. Ogawa M, Yonemura Y, Ku H. In vitro expansion of hematopoietic stem cells. Stem Cells 15(Suppl 1):7-11, 1997.
4. Metcalf D. Hematopoietic regulators: Redunduncy or subtlety? Blood 82:3515-3523, 1993.
5. Rennick D, Yang G, Muller-Sieburg C, Smith C, Arai N, Takabe Y, Gemmell L. Interleukin-4 (B-cell stimulating factor 1) can enhance or antagonize the factor-dependent growth of hemopoietic progenitor cells. Proc Natl Acad Sci U S A 84:6889-6895, 1987.
6. Bello-Fernandez C, Matyash M, Strobl H, Scheineckes C, Knapp W. Analysis of myeloid associated genes in human hematopoietic progenitor cells. Exp Hematol 25:1158-1166, 1996.
7. Marely S, Reilly I, Rassell N. IL-1 has positive and negative regulatory effects in human long-term bone marrow culture. Exp Hematol 29:75-79, 1992.
8. Aman MJ, Gub G, Aulitzky WE, Huber C. Inhibition of IL-11 by interferon-α in human bone marrow stromal cells. Exp Hematol 24:863-867, 1996.
9. Musachi M, Clark SC, Sudo T, Urdal DL, Ogawa M. Synergistic interactions between interleukin-11 and interleukin-4 in support of proliferation of primitive hematopoietic progenitors of mice. Blood 78:1448-1451, 1991.
10. Neben S, Donaldson D, Sieff C, Mauch P, Bodine D, Ferrara J, Yetz Aldape J, Turner K. Synergistic effects of interleukin-11 with other growth factors on the expansion of murine hematopoietic progenitors and maintenance of stem cells in liquid culture. Exp Hematol 22:353-359, 1994.
11. - cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor. Exp Hematol 21:1668-1672, 1993.
12. Tohda S, Kurokawa H, Nara N. Diversity and similarity in signaling pathways of hematopoietic growth factors in human leukemia cell lines. Leukemia 9:879-883, 1995.
13. Lowengerg B, Touw IP. Hematopoietic growth factors and their receptors in acute leukemia. Blood 81:281-292, 1993.
14. Dexter TM, Allen TD, Lajtha LG. Conditions controlling the proliferation of hematopoietic stem cells in vitro. J Cell Physiol 91:335-342, 1977.
15. + blood progenitors expressing different levels of c-kit protein. Eur J Haematol 58(4):257-264, 1997.
16. Kliegler AB, Bradley TR, Verschoor SM. Dual activity of CSF-1 produced by a murine cell line, and from other sources, on the growth of bone marrow stromal cells in culture. Exp Hematol 25:1118-1124, 1997.
17. Deryugina EI, Ratnikov BI, Bourdon MA, Gilmore GL, Shadduck RK, Muller-Siegurg CE. Identification of a growth factor for primary murine stroma as macrophage colony-stimulating factor. Blood 86:2568-2574, 1997.
18. Smith V. In vitro suppression of leukemia by alkylated interleukin-3. Leukemia 9:925-928, 1995.
19. Lotem J, Sachs L. Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor and oncogenes. Leukemia 10:925-931, 1996.
20. Petzer AL, Eaves CJ, Barnett MJ, Eaves AC. Selective expansion of primitive normal hematopoietic cells in cytokine-supplemented cultures of purified cells from patients with chronic myeloid leukemia. Blood 9:64-69, 1997.
21. Lang RA, Metcalf D, Gough NM, Dunn AR, Gonda TJ. Expression of a hemopoietic growth factor cDNA in a factor-dependent cell line results in autonomous growth and tumorigenicity. Cell 43:531-537, 1985.
22. Chang JM, Metcalf D, Lang RA, Gonda TJ, Johnson GR. Non-neoplastic hematopoietic myeloproliferative syndrome induced by dysregulated multi-CSF (IL-3) expression. Blood 73:1487-1492, 1989.
23. Laker C, Stocking C, Bergholz U, Hess N, De Lamarter JF, Ostertag W. Autocrine stimulation after transfer of the granulocyte-macrophage colony-stimulating factor gene and autonomous growth are distinct but interdependent steps in the oncogenic pathway. Proc Natl Acad Sci U S A 84:8458-8463, 1987.
24. Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, Armitage RJ. Human IL-17: A novel cytokine derived from T cells. J Immunol 155:5483-5486, 1995.
25. Saba HI. Myelodysplastic syndromes in the elderly: The role of growth factors in management. Leuk Res 20:203-219, 1996.
26. Hoang T, Haman A, Goncalves O, Wong GG, Clark SC. Interleukin-6 enhances growth factor-dependent proliferation of the blast cells of acute myeloblastic leukemia. Blood 72:823-826, 1988.
27. Moqattash S, Abraham NG, Lutton JD. Modulation of growth supportive and oncogenic properties of murine leukemic cells. Leuk Res 18:531-539, 1994.
28. Guualtieri RJ, Emanuel PD, Zuckerman KS, Martin G, Clark SC, Shadduck RK, Dracker RA, Akabutu J, Nitschke R, Hetherington ML, Dicherman DJ, Hakami N, Castleberry RP. Granulocyte-macrophage colony-stimulating factor is an endogenous regulator of cell proliferation in juvenile chronic myelogenous leukemia. Blood 74:2360-2366, 1989.
29. Emanuel PD, Bates LJ, Zhu S-W, Castleberry RP, Gualtieri RJ, Zuckerman KS. The role of monocyte-derived growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia. Exp Hematol 19:1017-1024, 1991.
30. + cells. Allerg Immunol (Paris) 29:7-10, 1997.
31. Sawyer ST, Penta K. Erythropoietin cell biology. Hematol Oncol Clin North Am 8:895-906, 1994.
32. Bhatia R, McGlave PB, Dewald GW, Blazar BR, Verfaillie CM. Abnormal function of the bone marrow microenvironment in chronic myelogenous leukemia: Role of malignant stromal macrophages. Blood 85:3636-3645, 1995.
33. Wetzler M, Kurzrock R, Estrov Z, Estey E, Talpaz M. Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemia. Leuk Res 19:23-34, 1995.
34. Bendall LJ, Daniel A, Kortlepel K, Gottlieb DJ. Bone marrow adherent layer inhibits apoptosis of acute myelogenous leukemia cells. Exp Hematol 22:1252-1260, 1994.
35. Dorshkind K. Regulation of hematopoiesis by bone marrow stromal cells and their products. Annu Rev Immunol 8:111-137, 1990.
36. Makrynikola V, Bradstock KF. Adhesion of precursor-B acute lymphoblastic leukemia cells to bone marrow stromal proteins. Leukemia 7:86-92, 1993.
37. Kincade PW, Lee G, Pietrangeli CE, Hayashi S-I, Gimble JM. Cells and molecules that regulate B-lymphopoiesis in bone marrow. Annu Rev Immunol 7:111-143, 1988.
38. Gimble JM, Hudson J, Henthorn J, Hua X, Burstein SA. Regulation of interleukin-6 expression in murine bone marrow stromal cells. Exp Hematol 19:1055-1060, 1991.
39. Gimble JM, Dorheim MA, Cheng Q, Medina K, Wang C-S, Jones R, Koren E, Pietrangeli CE, Kincade PW. Adipogenesis in a murine bone marrow stromal cell line capable of supporting B lineage lymphocyte growth and proliferation: Biochemical and molecular characterization. Eur J Immunol 20:379-387, 1990.
40. O'Prey J, Leslie N, Itoh K, Ostertag W, Bartholomew C, Harrison PR. Both stroma and stem cell factor maintain long-term growth of ELM erythroleukemia cells, but only stroma prevents erythroid differentiation in response to erythropoietin and interleukin-3. Blood 91:1548-1555, 1998.
41. Dexter TM. Stromal cell-associated haemopoiesis. J Cell Physiol Suppl 1:87-89, 1982.
42. Sosman JA, Stiff PJ, Bayer RA, Peliska J, Peace DJ, Loutfi S, Stock W, Oldenburg D, Unverzagt K, Bender J, Fisher SG, Weber L, Rad N, Kinch L. A phase-I trial of interleukin-3 (IL-3) pre-bone marrow harvest with granulocyte-macrophage colony-stimulating factor (GM-CSF) post-stem cell infusion in patients with solid tumors receiving high-dose combination chemotherapy. Bone Marrow Transplant 16:655-361, 1995.
43. Yu WG, Ogawa M, Mu J, Umehara K, Tsujimura T, Fujiwara T. Interleukin-12 induced tumor regression correlates with in situ activity of INF-γ produced by tumor-infiltrating cells and its secondary induction. J Leukoc Biol 62:450-457, 1997.
44. Tsujimoto Y, Crossman J, Jaffe E, Croce C. Involvement of the bcl-2 gene in human follicular lymphoma. Science 228:1440-1443, 1985.
45. Vaux D, Cary S, Adams J. Bcl-2 gene promotes hematologic cell survival and cooperates with c-myc to immortalize pre-B-cells. Nature 335:440-442, 1988.
46. Bhat A, Kolibaba K, Oda T, Ohno-Jones S, Heaney C, Druker BJ. Interaction of CBL with BCR-ABL and CRKL in BCR-ABL transformed myeloid cells. J Biol Chem 272:16170-16175, 1997.
47. Beyermann B, Adams HP, Henze G. Philadelphia chromosome in relapsed childhood acute lymphoblastic leukemia: A matched-pair analysis. J Clin Oncol 15:2231-2237, 1997.
48. Grossmann A, Lenox J, Ren HP, Humes JM, Forstrom JW, Kaushansk K, Sprugel KH. Thrombopoietin accelerates platelet red blood cell and neutrophil recovery in myelosuppressed mice. Exp Hematol 2-4:1238-1246, 1996.
49. Kaushansky K, Lin N, Grossmann A, Humes J, Sprugel KH, Broudy VC. Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice. Exp Hematol 24:265-269, 1996.
50. Eaton DL, Sauvage FJ. Thrombopoietin: The primary regulator of megakaryocytopoiesis and thrombopoiesis. Exp Hematol 25:1-7, 1997.
51. Ohtsuki T, Hatake K, Ikeda M. Yamada M, Motoyoshi K, Miura Y. Binding of macrophage colony-stimulating factor to serum proteins. Exp Hematol 24:101-107, 1996.
52. Xing Z, Braciak T, Ohkawara Y, Sallenave JM, Foley R, Sime PJ, Jordana M, Graham FL, Gauldie J. Gene transfer for cytokine functional studies in the lung: The multifunctional role of GM-CSF in pulmonary inflammation. J Leukoc Biol 59:481-488, 1996.
53. Li Y, Valeriot F, Chen B. Regulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors in a GM-CSF-dependent human myeloid leukemia cell line (AML-193) by interleukin-6. Exp Hematol 24:94-100, 1996.
54. Wong GG, Temple PA, Leary AC, Witek-Giannotti JS, Yang Y, Ciarletta AB, Chung M, Murtha P, Kriz R, Kaufman RJ, Ferenz CR, Sibley BS, Turner KJ, Hewick RM, Clark SC, Yanai N, Yokota H, Yamada M, Saito M, Motoyoshi K, Takaku F. Human CSF-1: Molecular cloning and expression of 4-kb cDNA encoding the human urinary protein. Science 235:1504-1511, 1987.
55. Kimura F, Douzono M, Ohta J, Morita T, Ikeda K, Nakamura Y, Sato K, Yamada M, Nagata N, Motoyoshi K. Augmentation of antitumor activity using genetically M-CSF-expressing L1210 cells. Exp Hematol 24:360-363, 1996.
56. Areci RJ, Shanahan F, Stanley ER, Pollard JW. Temporal expression and location of colony stimulating factor-1 (CSF-1) and its receptor in the female reproductive tract are consistent with CSF-1-regulated placental development. Proc Natl Acad Sci USA 86:8818-8823, 1989.
57. Bock SN, Cameron RB, Kragel P, Mule JJ, Rosenderg T. Biological and antitumor effect of recombinant macrophage colony-stimulating factor in mice. Cancer Res 51:2649-2654, 1991.
58. Demitry G, Griffin JD. Granulocyte colony-stimulating factor and its receptors. Blood 78:2791-2806, 1991.
59. Phillips N, Jacobs S, Stoller R, Earl M, Przepiorka D, Shadduck RK. Effects of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in patients with refractory metastatic carcinoma. Blood 74:26-34, 1989.
60. Metcalf D, Morstyn G. Colony-stimulating factors: General biology. In: DeViya VT, Hellman S, Rosenberg SA, Eds. Biologic Therapy of Cancer. Philadelphia: Lippincott, p. 417, 1991.
61. Cesana C, Carlo-Stella C, Mangoni L, Reggazi E, Garau D, Sammarelli G, Caramatti C, Almici C, Rizzoli V. In vitro growth of mobilized peripheral blood progenitor cells is significantly enhanced by stem cell factor. Stem Cells 15:207-213, 1997.
62. Fantuzzi G, Dinarello CA. The inflammatory response in IL-1b-deficient mice: Comparison with other cytokine-related knockout mice. J Leukoc Biol 59:489-193, 1996.
63. Yin T, Yasukawa K, Taga T, Kishimoto T, Yang YC. Identification of a 130-kilodalton tyrosine phosphorylated protein induced by IL-11 as JAK2 tyrosine kinase, which associates with gp130 signal transducer. Exp Hematol 22:467-472, 1994.
64. Taga T, Tsang M L-S, Yasukawa K, Kishimoto T, Tang Y-C. Involvement of interleukin-6 signal transducer gp130 in interleukin-11 mediated signal transduction. J Immunol 151:2555-2561, 1993.
65. Ip NY, Nye SH, Boulton TG, Davis S, Taga T, Li Y, Birren SJ, Yasukawa K, Kishimoto T, Anderson DJ, Stahl N, Yancopoulos GD. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transduction receptor component gp130. Cell 69:1121-1132, 1992.
66. Liu J, Modrell B, Aruffo A, Marken JS, Taga T, Yasukawa Y, Murakami M, Kishimoto T, Shoyab M. Interleukin-6 signal transducer gp130 mediates oncostatin M signaling. J Biol Chem 267:16763-16766, 1992.
67. Aman MJ, Keller U, Derigs G, Mohamadzadeh M, Huber C, Peschel C. Regulation of cytokine expression by interferon α in human bone marrow stromal cells: Inhibition of hematopoietic growth factors and induction of IL-1 receptor antagonist. Blood 83:4142-4156, 1994.
68. Ezaki K. Cytokine therapy for hematological malignancies. Intl J Hematol 65:17-29, 1996.
69. Khoruts A, Mondino A, Pape KA, Reiner SL, Jenkins MK. A natural immunological adjuvant enhances T-cell clonal expansion through a CD28-dependent, interleukin (IL)-2-independent mechanism. J Exp Med 187(2):225-236, 1998.
70. Zlotnik A, Fisher M, Roehm N, Zipori D. Evidence for effect of interleukin-4 (B-cell stimulating factor-1) on macrophages: Enhancement of antigen presenting ability of bone marrow-derived macrophages. J Immunol 138:4275-1281, 1987.
71. Favre C, Seeland S, Caux C, Duvert V, De Varies JE. Interleukin-4 has basophilic and eosinophilic cell growth-promoting activity on cord blood cells. Blood 75:67-73, 1990.
72. - blasts from acute myelogenous leukemia. Blood 78:197-204, 1991.
73. Imai Y, Nara N, Nagata K, Suzuki T, Nagasawa M, Murohashi I, Aoki N. Antiproliferative and differentiative effects of recombinant interleukin-4 on a granulocyte colony-stimulating factor-dependent myeloblastic leukemia cell line. Blood 78:471-478, 1991.
74. Schutze S, Matchledt T, Knock M. The role of diacylglycerol and ceramide in TNF and IL-1 signal transduction. J Leukoc Biol 56:533-541, 1994.
75. Jansen JH, Wietjens G-J HM, Fibbe WE, Willemze R, Kluin-Nelemans HC. Inhibition of human macrophage colony formation by interleukin-4. J Exp Med 170:577-582, 1989.
76. Seow HF, David MJ, McWaters P, Hurst L, Wood PR. Cloning and sequencing of an ovine interleukin-5 cDNA. DNA Seq 6:331-335, 1996.
77. Sedgwick JB, Busse WW. Inhibitory effect of cetirizine on cytokine-enhanced in vitro eosinophil survival. Ann Allergy Asthma Immunol 78:581-585, 1997.
78. Mufson RA, Aghajanian J, Wong G, Woodhouse C, Morgan AC. Macrophage colony-stimulating factor enhances monocyte and macrophage antibody-dependent cell-mediated cytotoxicity. Cell Immunol 119:182-192, 1989.
79. Bluethmann H, Rothe J, Schultze N, Tkachuk M, Koebel P. Establishment of the role of IL-6 and TNF receptor 1 using gene knockout mice. J Leukoc Biol 56:565-570, 1994.
80. Wiryana P, Bui T, Faltyneck CR, Ho RJ. Augmentation of cell-mediated immunotherapy against herpes simplex virus by interleukins: Compression of in vivo effects of IL-2 and IL-7 on adoptively transferred T cells. Vaccine 15:561-563, 1997.
81. Tang J, Nuccie BL, Ritterman I, Liesveld JL, Abboud CN, Ryan DH. TGF-β downregulates stromal IL-7 secretion and inhibits proliferation of human B-cell precursors. J Immunol 159:117-125, 1997.
82. Leong KH, Ramshaw IA, Ramsay AJ. Interleukin-7 enhances cell-mediated immune responses in vivo in an interleukin-2-dependent manner. Viral Immunol 10:1-9, 1997.
83. Wang JB, Zhang Y, Kasahara T, Harada A, Matsushima K, Mukaida N. Detection of mouse IL-8 receptor homolog expression on peripheral blood leukocytes and mature myeloid lineage cells in bone marrow. J Leukoc Biol 60:372-381, 1996.
84. Broxmeyer HE, Sherry B, Cooper S, Lu L, Maze T, Beckmann MP, Cerami A, Ralph P. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells: Interacting effects involving suppression, synergistic suppression, and blocking of suppression. J Immunol 150:3448-3458, 1993.
85. Yasumoto K, Okamoto S, Mukaida N, Murakami S, Mai M, Matsushima K. Tumor necrosis factor-α and interferon-γ synergistically induce interleukin-8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-χ B-like binding sites of the interleukin-8 gene. J Biol Chem 267:22506-22511, 1992.
86. Harada A, Sekido N, Akahoshi T, Wada T, Mukaida N, Matsushima K. Essential involvement of interleukin-8 in acute inflammation. J Leukoc Biol 56:559-564, 1994.
87. - or low cord blood cells on cytokine-stimulated erythroid colony formation. Exp Hematol 2-4:347-351, 1996.
88. Xiao M, Yang YC, Yang L, Chang MS, Cometta K, Broxmeyer HE, Lu L. Transduction of human interleukin-9 receptor gene into human cord blood erythroid progenitors increases the number of erythropoietin-dependent erythroid colonies. Bone Marrow Transplant 18:1103-1109, 1996.
89. Madesen KL, Lewis SA, Tavernini MM, Hibbard J, Fedorak RN. Interleukin-10 prevents cytokine-induced disruption of T84 monolayer barrier integrity and limits chloride secretion. Gastroenterology 113:151-159, 1997.
90. Zocchia C, Spiga G, Rabin SJ, Grekova M, Kichert J, Chernyshev O, Colton C, Mocchetti I. Biological activity of interleukin-10 in the central nervous system. Neurochem Int 30:433-439, 1997.
91. Seow HF, David MJ, McWaters P, Hurst L, Wood PR. Cloning and sequencing of an ovine interleukin-5 cDNA. DNA Seq 6:331-335, 1996.
92. Keller DC, Du XX, Srour EF, Hoffman R, Williams DA. Interleukin-11 inhibits adipogenesis and stimulates myelopoiesis in human long-term marrow cultures. Blood 82:1428-1435, 1993.
93. Brunda MJ. Interleukin-12. J Leukoc Biol 55:280-288, 1994.
94. Trinchieri G, Gerosa F. Immunoregulation by interleukin-12. J Leukoc Biol 59:505-511, 1996.
95. Defrance T, Caryon P, Billian G, Guillemot J-C, Minty A, Caput D, Ferrara P. Interleukin-13 is a B-cell stimulating factor. J Exp Med 179:135-143, 1994.
96. Jinquan T, Deleuran B, Gesser B, Maare H, Deleuran M, Larsen CG, Thestrup-Pedersen K. Regulation of human lymphocyte chemotaxis in vitro by T-cell-derived cytokines IL-2, INF-α, IL-4, IL-10, and IL-13. J Immunol 154:3742-3752, 1995.
97. Ford R, Tamayo A, Martin B, Niu K, Claypool K, Cabanillas F, Ambrus J. Identification of B-cell growth factors (interleukin-14; high molecular weight-B-cell growth factors) in effusion fluids from patients with aggressive B-cell lymphomas. Blood 86:283-293, 1995.
98. Grabstein KH, Eiseman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, Johnson L, Alderson MR, Watson JD, Anderson DM, Giri JG. Cloning of a T-cell factor that interacts with the β chain of the interleukin-2 receptor. Science 264:965-968, 1994.
99. Carson WE, Giri JG, Lindermann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eiseman J, Crabstein KH, Caligiuri MA. Interleukin-15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 180:1395-1403, 1994.
100. Armitage RJ, Macduff BM, Eiseman J, Paxton R, Crabstein KH. Interleukin-15 has stimulatory activity for the induction of B-cell proliferation and differentiation. Am Assoc Immunol 154:483-490, 1996.
101. Eiseman J, Crabstein KH, Caligiuri MA. Interleukin-15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 180:1395-1403, 1994.
102. Mingari MC, Viyale C, Cantoni C, Bellomo R, Ponte M, Schiavelti F, Bertone S, Moretta A, Moretta L. Interleukin-15 induced maturation of human natural killer cells from early thymic precursors: Selective expression of CD4/NKG2-A as the only HLA class 1-specific inhibitory receptor. Eur J Immunol 27:1374-1380, 1997.
103. Zhou P, Goldstein S, Devadas K, Tewari D, Notkins AL. Human CD4 cells transfected with IL-16 cDNA are resistant to HIV-1 infection: Inhibition of mRNA expression. Nat Med 3:659-664, 1997.
104. Bair M, Bannert N, Werner A, Lang K, Kurth R. Molecular cloning, sequencing, expression, and processing of the interleukin-16 precursor. Proc Natl Acad Sci USA 94:5273-5277, 1997.
105. Kennedy J, Rossi DL, Zurawski SM, Vega F Jr. Kastelein RA, Wagner JL, Hannum CH, Zlotnik A. J Interferon Cytokine Res 16:611-617, 1996.
106. Stoll S, Muller G, Kurimoto M, Saloga J, Tanimoto T, Yamauchi H, Okamura H, Knop J, Enk AH. Interleukin-18 (INF-gamma inducing factor) messenger RNA and functional protein by murine keratinocytes. J Immunol 159:298-302, 1997.
107. Matsumoto S, Tsuji-Takayama K, Aizawa Y, Koide K, Takeuchi M, Ohta T, Kurimoto M. Interleukin-18 activates NF-κB in murine T-helper type 1 cells. Biochem Biophys Res Commun 234:454-457, 1997.
108. Yoshimoto T, Okamura H, Tagawa YI, Iwakura Y, Nakanishi K. Interleukin-18 together with interleukin-12 inhibits IgE production by induction of interferon-gamma production from activated B cells. Proc Natl Acad Sci USA 94:3948-3953, 1997.
109. Nara N, Kurokana H, Tohda S, Tomiyama T, Nagata K, Tanikawa S. The effect of basic and acidic fibroblast growth factors (bFGF and aFGF) on the growth of leukemic blast progenitors in acute myelogenous leukemia. Exp Hematol 23:1030-1034, 1995.
110. Gabbianelli M, Sargiacomo M, Pelosi E, Testa U, Isacchi G, Peshle C. "Pure" human hematopoietic progenitors: Permissive action of basic fibroblast growth factor. Science 249:1561-1564, 1990.
111. Wilson EL, Rifkin DB, Kelly F, Hannocks M-J, Gabrilove JL. Basic fibroblast growth factor stimulates myelopoiesis in long-term human bone marrow cultures. Blood 77:954-960, 1991.
112. Abboud SL, Pinzani M. Peptide growth factors stimulate macrophage colony-stimulating factor in murine stromal cells. Blood 78:103-109, 1991.
113. Karres I, Kremer J-P, Steckholzer U, Kenney JS, Ertel W. Transforming growth factor-β 1 inhibits synthesis of cytokines in endotoxin-stimulated human whole blood. Arch Surg 131:1310-1317, 1996.
114. Metcalf D. The molecular control of proliferation and differentiation in hemopoietic cells. C R Acad Sci III 316:860-870, 1993.
115. Shabo Y, Lotem J, Rubinstein M, Revel M, Vlark SC, Wolf SF, Kamen R, Sachs L. The myeloid blood cell differentiation-induced protein MGL-2A is interleukin-6. Blood 72:2970-2073, 1988.
116. Piacibello W, Sanavio F, Severino A, Morelli S, Vaira AM, Stacchini A, Aglietta M. Opposite effect of tumor necrosis factor-α on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors. Cancer Res 50:5065-5071, 1990.
117. Maekawa T, Sonoda Y, Kusuyama Y, Inazawa J, Kimura S. Synergistic suppression of the clonogenicity of U937 leukemic cells by combinations of recombinant human IL-4 and G-CSF. Exp Hematol 20:1201-1207, 1992.
118. Sing GK, Keller JR, Ellingworth LR, Ruscetti FW. Transforming growth factor-β selectively inhibits normal and leukemic human bone marrow cell growth in vitro. Blood 72:1504-1511, 1988.
119. Koistinen P, Saily M, Poromaa N, Savolainen ER. Complex effects of interleukin-6 on clonogenic blast cell growth in acute myeloblastic leukemia. Acta Haematol 98:14-21, 1997.
120. Kinoshita T, Yokota T, Miyajima A. Suppression of apoptotic death in hematopoietic cells by signaling through the IL-3, GM-CSF receptors. EMBO J 14:266-272, 1997.
121. Francia di Celle P, Mariani S, Riera L, Stacchini A, Reato G, Foa R. Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion. Blood 87:4382-4389, 1996.
122. Miyauchi J, Clark C, Tsunematsu Y, Shimizu K, Park JW, Ogawa T, Toyama K. Interleukin-4 as a growth regulator of clonogenic cells in acute myelogenous leukemia in suspension cultures. Leukemia 5:108-115, 1991.
123. Kantarjian HM, Deisseorth A, Kurzrock R, Estrov Z, Talpaz M. Chronic myelogenous leukemia: A concise update. Blood 82:691-703, 1993.
124. Silver RT. A new treatment for polycythemia vera: Recombinant interferon alpha. Blood 76:664-665, 1990.
125. Giles FJ, Singer CR, Gray AG, Yong KL, Brozovic M, Davies SC, Grants IR, Hoffbrand AV, Machin SJ, Mehta AB. α-interferon therapy for essential thrombocythemia. Lancet 2:70-72, 1988.
126. Logan TF, Gooding W, Kirkwood JM, Shadduck RK. Tumor necrosis factor administration is associated with increased endogenous production of M-CSF and G-CSF but not GM-CSF in human cancer patients. Exp Hematol 24:49-53, 1996.
127. Ross HJ, Koeffler HP. Interactions between TNF and GM-CSF. In: Beutler B, Ed. Tumor necrosis factors: The Molecules and their Emerging Role in Medicine. New York: Raven Press, 179, 1992.
128. Phillips N, Jacobs S, Stoller R, Earl M, Przepiorka D, Shadduck RK. Effects of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in patients with refractory metastatic carcinoma. Blood 74:26-34, 1989.
129. Armstrong E, Vainikka S, Partanen J, Korhenen J, Alitalo R. Expression of fibroblast growth factor receptors in human leukemia cells. Cancer Res 52:2004-2007, 1992.
130. Hl S, Schwaberu M, Pluznik DH. Interleukin-1 augments the expression of the interleukin-2 receptor α-chain in interleukin-6-stimulated myeloid cells by a transcriptional and post transcriptional mechanism. Exp Hematol 20:1208-1215, 1992.
131. Tosato G, Miller J, Marti G, Pike SE. Accessory function of interleukin-1 and interleukin-6: Preferential costimulation of T4 positive lymphocytes. Blood 75:922-930, 1990.
132. Chiu CP, Lee F. Interleukin-6 is a differentiation factor for M1 and WEHL-3B myeloid leukemia cells. J Immunol 142:1909-1915, 1989.
133. Pluznik DH, Fridman R, Reich R. Correlation in the expression of type IV collagenase and the invasive and chemotactic abilities of myelomonocytic cells during differentiation into macrophages. Exp Hematol 20:57-63, 1992.
134. Onozaki K, Urawa H, Tamatani T, Iwamura Y, Hashimoto T, Baba T, Suzuki H, Yammada M, Yamamoto S, Oppenheim JJ, Matsushima K. Synergistic interaction of interleukin-1, interferon-β, and tumor necrosis factor in terminally differentiating mouse myeloid leukemic cell line (M1). J Immunol 140:112-119, 1988.
135. Takeda K, Iwamoto S, Sugimoto H, Takuma T, Kawatani N, Noda M, Masaki A, Morise H, Arimura H, Konno K. Identity of differentiation inducing factor and tumor necrosis factor. Nature 323:338-345, 1986.
136. Trinchieri G, Kobayashi M, Rosen M, Loudon R, Murphy M, Perussia B. Tumor necrosis factor and lymphotoxin induce differentiation of human myeloid cell lines in synergy with immune interferon. J Exp Med 164:1206-1211, 1986.
137. Wang S-Y, Chen L-Y, Wang S-T, Lin C-K. Growth inhibition and differentiation in HL60 leukemia cells induced by 1,25 dihydroxy vitamin D3 and tumor necrosis factor-α. Exp Hematol 19:1025-1030, 1991.
138. Rao KMK, Misukonis MA, Cohen HJ, Weinberg JB. Cooperative effect of tumor necrosis factor and γ-interferon on chemotactic peptide receptor expression and stimulus-induced actin polymerization in HL-60 cells. Blood 71:1062-1067, 1988.
139. Geissler K, Tricot G, Leemhuis T, Walker E, Broxmeyer HE. Differentiation-induced effect of recombinant human tumor necrosis factor-α and γ-interferon in vitro on blast cells from patients with acute myeloid leukemia and myeloid blast crisis of chronic myeloid leukemia. Cancer Res 49:3057-3067, 1989.
140. 2 plus TNF in induction of differentiation of human monocytoid leukemic U937 cells. Anticancer Res 9:615-618, 1989.
141. Nastala CL, Edington HD, McKinney TG, Tahara H, Nalesnik MA, Brunda MJ, Galdy WJ, Wolf SF, Schreiber RD, Storkus WJ, Lotz MT. Recombinant interleukin-12 administration induces tumor regression in association with INF-γ production. J Immunol 153:1697-1706, 1994.
142. Cesana C, Carlo-Stella C, Mangoni L, Reggazi E, Garau D, Sammarelli G, Caramatti C, Almici C, Rizzoli V. In vitro growth of mobilized peripheral blood progenitor cells is significantly enhanced by stem cell factor. Stem Cells 15:207-213, 1997.
143. Bamford RN, Battiata AP, Waldmann TA. IL-15: The role of translational regulation in their expression. J Leukoc Biol 59:470-480, 1996.
144. Vidal-Vanaclocha F, Mezaga C, Asumendi A, Kaplanski C, Dinarello CA. Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastasis. Cancer Res 54:2667-2672, 1994.
145. Sawai N, Koike K, Ito S, Okumura N, Kamijo T, Shiohara M, Amano Y, Tsuji K, Nakahata T, Oda M, Komiyama A. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture. Exp Hematol 24:116-122, 1996.
146. - progenitor cells in long-term cultures and short-term colony assays. Blood 81:2916-2923, 1993.
147. Altman AJ, Palmer CG, Baehner RL. Juvenile "chronic granulocytic" leukemia: A panmyelopathy with prominent myelocytic involvement and circulating monocyte forming cells. Blood 43:341-345, 1974.
148. 1 arrest by retinoic acid and 1,25 dihydroxyvitamin D3. Cancer Lett 27:125-134, 1985.
149. Just U, Spooncer E, Lohler J, Stocking C, Ostertag W, Dexter TM. Mutants of a multipotent hematopoietic cell line blocked in GM-CSF-induced differentiation are leukemogenic in vivo. Exp Hematol 22:933-940, 1994.
150. Miyashita T, Reed JC. Bcl-2 oncoprotein blocks chemotherapy induced apoptosis in a human leukemia cell line. Blood 81:151-157, 1993.
151. Paglia D, Oran A, Lu C, Kerbel RS, Sauder DN, McKenzie RC. Expression of leukemia inhibitory factor and IL-11 by human melanoma cell lines: LIF, IL-6, and IL-11 are not coregulated. J Interferon Cytokine Res 15:455-160, 1995.
152. Brodsky RA, Bedi A, Jones RJ. Are growth factors leukemogenic? Leukemia 10:175-177, 1996.
153. Lacronique V, Varlet P, Mayeux P, Porteu A, Gisselbrecht S, Kahn A, Lacombe C. Bcl-2 targeted over expression into the erythroid lineage of transgenic mice delays but does not prevent the apoptosis of erythropoietin-deprived erythroid progenitors. Blood 90:3050-3056, 1997.
154. Bedi A. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 83:2038-2044, 1994.
155. Sachs L, Lotem J. Control of programmed cell death in normal and leukemic cells: New implications for therapy. Blood 82:15-21, 1993.
156. Kurzrock R, Kantarjian H, Wetzler M, Estrov Z, Estey E, Troutman-Worden K, Gutterman JU, Talpaz M. Ubiquitous expression of cytokines in diverse leukemias in lymphoid and myeloid lineage. Exp Hematol 21:80-85, 1993.
157. Wetzler M, Kurzrock R, Lowe DG, Kantarjian H, Gutterman JU, Talpaz M. Alteration in bone marrow adherent layer growth factor expression: A novel mechanism of myelogenous leukemia progression. Blood 78:2400-2406, 1991.
158. Mori N, Shirakawa F, Murakami S, Oda S, Eto S. Characterization and
159. Satoh M, Mioh H, Konishi N, Takahash I, Tamaoki T. Characterization of the molecules involved in the hematopoietic microenvironment provided by mouse stromal cell line MC3T3-G2PA6 using a unique reporter system that analyzes the direct cell-to-cell interaction. Acta Haematol 98:95-103, 1997.
160. Guilhot F, Chastang C, Michallet M, Guerci A, Harousseau JL, Maloisel F, Bouabdallah R, Guyotat D, Cheron N, Nicolini F, Abgrall JF, Tanzer J. Interferon α-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia: French myeloid leukemia study group. N Engl J Med 337:270-271, 1997.
161. Tavassoli M, Friedenstein A. Hematopoietic stromal environment. Am J Hematol 15:195-203, 1983.
162. Torok-Storb B. Cellular interactions. Blood 73:373, 1988.
163. Gartner S, Kaplan HS. Long-term culture of human bone marrow cells. Proc Natl Acad Sci USA 77:4756-4759, 1980.
164. + stem cells to bone marrow stroma. J Clin Invest 90:358-367, 1992.
165. Rosenblatt M, Vuillet-Gaugler MH, Leroy C, Coulombet L. Coexpression of two fibronectin receptors, VLA-4 and VLA-5, by immature human erythroblastic precursor cells. J Clin Invest 87:6-11, 1991.
166. + cells with stromal cells. Acta Haematol 98(S1):502-511, 1997.
167. Peled A, Lee BC, Toledo J, Aracil M, Zipori D. Interactions between leukemia cells and bone marrow stromal cells: Stroma-supported growth vs. serum dependence and the roles of TGF-β and M-CSF. Exp Hematol 24:728-737, 1996.
168. Mayani H. Composition and function of the hemopoietic microenvironment in human myeloid leukemia. Leukemia 10:1041-1047, 1996.
169. Bendall JL, Kortlepel K, Gottlieb JD. Bone marrow fibroblast exposure to the inflammatory cytokines tumor necrosis factor-α and interferon-γ increases adhesion of acute myeloid leukemia cells and alters the adhesive mechanism. Exp Hematol 25:132-133, 1997.
170. Manabe A, Coustan-Smith E, Behm FG, Raimondi SC, Campana D. Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. Blood 79:2370-2377, 1992.
171. Rameshwar P, Gascon P. Hematopoietic modulation by tachykinins. Acta Haematol 98:59-64, 1997.
172. Jovcic G, Ivanovic Z, Biljanovic-Paunovic L, Bugarski D, Stosic-Grujicic S, Milenkovic P. The effect of IL-1 receptor antagonist on the proliferation of hematopoietic progenitor cells in regenerating bone marrow. Leukemia 10:564-569, 1996.
173. Van Snick J. Interleukin-6: An overview. Annu Rev Immunol 8:253-278, 1990.
174. Slack JL, Nemunaitis J, Andrews DF III, Singer JW. Regulation of cytokine and growth factor gene expression in human bone marrow stromal cells transformed with simian virus 40. Blood 75:2319-2327, 1990.
175. Auffray I, Dubart A, Izac B, Vainchenker W, Coulombel L. A murine stromal cell line promotes the proliferation of the human factor-dependent leukemic cell line UT-7. Exp Hematol 22:417-425, 1994.
176. Zanjani E, Pallavicini MG, Ascensao JL, Flake AW, Langlois RG, Reitsma M, MacKintosh FR, Stutes D, Harrison M, Tavassoli M. Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero. J Clin Invest 89:1178-1188, 1992.
177. Lapidot T, Pflumio F, Doedens M, Murdoch B, Williams D, Dick J. Stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 255:1137-1145, 1992.
178. - progenitor cells in long-term cultures and short-term colony assays. Blood 81:2916-2924, 1993.
179. Sutherland H, Eaves CJ, Lansdorp PM, Thacker JD, Hogge DE. Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells. Blood 78:666-672, 1991.
180. Baum CM, Weisman IL, Tsukamato AS, Buckle AM, Peault B. Isolation of a candidate human hematopoietic stem cell population. Proc Natl Acad Sci USA 89:2804-2808, 1992.
181. Lotem J, Sachs L. Control of apoptosis in hematopoiesis and leukemia by cytokines, tumor suppressor, and oncogenes. Leukemia 10:925-931, 1996.
182. Jewell AP. Interferon-α, Bcl-2 expression and apoptosis in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 21:43-47, 1996.
183. Murohashi I, Yoshida K, Handa A, Murayoshi M, Yoshida S, Jinnai I, Bessho M, Hirashima K. Differential regulation of hematopoietic growth factors of apotosis and mitosis in acute myeloblastic leukemia cells. Exp Hematol 25:1042-1050, 1997.
184. Baselga J, Norton L, Masui H, Pandiella A, Coplan K, Miller WH Jr, Mendelsohn J. Antitumor effects of doxorubicin in combination with antiepidermal growth factor receptor monoclonal antibodies. J Natl Cancer Inst 85:1327-1332, 1993.
185. Colotta F Re, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80:2012-2020, 1992.
186. Spiekermann K, O'Brien S, Estey E. Relapse of acute myelogenous leukemia during low-dose interleukin-2 (IL-2) therapy. Phenotypic evolution associated with strong expression of the IL-2 receptor α-chain. Cancer 75:1594-1597, 1995.
187. Brach MA, deVos S, Gruss H, Herrmann F. Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood 80:2920-2924, 1992.
188. Lowe SW, Ruley HE, Jacks T, Housman DE. P53-dependent apoptosis modulates the cytotoxicity of anticancer asents. Cell 74:957-967, 1993.
189. Ganser A. Hematopoietic growth factors in the treatment of the myelodysplastic syndromes. Curr Opin Hematol 2:204-209, 1995.
190. Estey E, Thall PF, Kantarjian H, O'Brien S, Koller CA, Beran M, Gutterman J, Deisseroth A, Keatin M. Treatment of newly diagnosed acyte myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-C + daunorubicin: Comparison to patients treated without GM-CSF. Blood 79:2246-2255, 1992.
191. Collins MKL, Marvel J, Malde P, Lopez-Rivas A. Interleukin-3 protects bone marrow cells from apoptosis induced by DNA damaging agents. J Exp Med 176:1043-1051, 1992.
192. Lotem J, Sachs L. Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor-β1 and cancer chemotherapy compounds in myeloid leukemia cells. Blood 80:1750-1757, 1992.
193. Heidenreich S, Otte B, Lang D, Schmidt M. Infection by Candida albican inhibits apoptosis of human monocytes and monocytic U937 cells. J Leukoc Biol 60:737-743, 1996.
194. Kikuchi H, Lizuka R, Sugiyama S, Gon G, Mori H, Arai M-A, Mizumoto K, Imajoh-Ohmi S. Monocytic differentiation modulates apoptotic response to cytotoxic anti-fas antibody and tumor necrosis factor α in human monoblast U937 cells. J Leukoc Biol 60:778-783, 1996.
195. Lotem J, Sachs L. Regulation of bcl-2, bcl-x1, and bax in the control of apoptosis by hematopoietic cytokines and dexamethazone. Cell Growth Differ 6:647-653, 1995.
196. Nemunaitis J. A comparative review of colony-stimulating factors. Drugs 54:709-729, 1997.
197. Glaspy JA, Golde DW. Clinical applications of the myeloid growth factors. Semin Hematol 26:14-17, 1989.
198. Nimer SD, Paquette RL, Ireland P, Resta D, Young D, Golde DW. A phase I/II study of interleukin-3 in patients with aplastic anemia and myelodysplasia. Exp Hematol 22:875-880, 1994.
199. Sachs L. The molecular control of hemopoiesis and leukemia. C R Acad Sci III 316:871-891, 1993.
200. + cells and CML mononuclear cells. Stem Cells 15:386-395, 1997.
201. Ahmed T, Lutton JD, Feldman E, Tani K, Asano S, Abraham NG. Gene transfer of α-interferon into hematopoietic stem cells. Leuk Res 22:119-124, 1998.
202. Bruserud O, Tore Gjertsen B, Bassoe C-F, Neshus I, Espen Akselsen P, Buhring H-J. Effects of IL-10 on blast cells derived from patients with acute myelogenous leukemia. Leukemia 9:1910-1920, 1995.
203. Shadduck RK, Fischer BC, DePasquale DK, Gilmore GL. Paradoxical stimulation of normal and leukemic rat hematopoiesis by monoclonal antibody to CSF-1 receptor. Exp Hematol 24:314-317, 1996.
204. Bock SN, Cameron RB, Kragel P, Mule JJ, Rosenderg T. Biological and antitumor effect of recombinant macrophage colony-stimulating factor in mice. Cancer Res 51:2649-2654, 1991.
205. Walsh P, Dorner A, Duke RC, Su L-J, Golde LM. Macrophage colony-stimulating factor complementary DNA: A candidate for gene therapy in metastatic melanoma. J Natl Cancer Inst 87:809-816, 1995.
206. Murohashi I, Endho K, Nishida S, Yoshida S, Jinnai I, Besho M, Hirashima K. Differential effects of TGF-β1 on normal and leukemic human hematopoietic cell proliferation. Exp Hematol 23:970-977, 1995.
207. Eaton DL, Sauvage FJ. Thrombopoietin: The primary regulator of megakaryocytopoiesis and thrombopoiesis. Exp Hematol 25:1-7, 1997.
208. Farese AM, Hunt P, Grab LB, MacVittie TJ. Combined administration of recombinant megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia. J Clin Invest 97:2145-2151, 1996.
209. Fibbe WE, Heemskerk DPM, Laterveer Pruijt JFM, Foster D, Kauahansky K, Willemze R. Accelerated reconstitution of platelets and erythrocytes after syngenic transplantation of bone marrow cells derived from TPO pretreated donor-mice. Blood 86:3308-3313, 1995.
210. Tohyama K, Ueda T, Yoshida Y, Nakamura T. Altered responses of purified blast cells from the myelodysplastic syndromes to colony-stimulating factors in vitro: Contrast with normal blast cells. Exp Hematol 22:539-547, 1994.
211. Aulitzky WE, Huber C, Peschel C. Cytokine therapy of neoplastic and inflammatory disease. Int Arch Allergy Immunol 101:221-226, 1993.
212. Yunis JJ, Boot AJM, Mayer MG, Bos JL. Mechanism of ras mutation in myelodysplastic syndrome. Oncogene 4:609-614, 1989.
213. Hirai H, Kobayashi Y, Mano H, Hagiwara K, Maru Y, Omine M, Mizoguchi H, Nishida J, Takaku F. A point mutation at code 13 of the N-ras oncogene in myelodysplastic syndrome. Nature 327:430-436, 1987.
214. 1 integrins expressed on haematopoietic cell lines. Blood 85:159-167, 1995.
215. Mitsuya H, Weinhold KJ, Furman PA, Clair MH, Lehrman SN, Gallo RC, Bolognesi D, Barry DW, Broder S. 3-azido-3-deoxythymidine BW A509UO: An antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus. Proc Natl Acad Sci USA 82:7096-7103, 1985.
216. Ho DD, Hartshorn KL, Rota TR, Andrews CA, Kaplan JC, Schooley RT, Hirsch MS. Recombinant human interferon-α suppresses HTLV-III replication in vitro. Lancet 1(8429):602-604, 1985.
217. Hartshorn KL, Vogt MW, Chou TC, Blumberg RS, Byington R, Schooley RT, Hirsch MS. Synergistic inhibition of human immunodeficiency virus in vitro by azidothimidine and recombinant α-interferon. Antimicrob Agents Chemother 31:168-175, 1987.
218. Moqattash S, Lutton JD, Abu-Hijleh MF, Abraham NG. Hemopoietic recovery from AZT toxicity with recombinant hemoglobin in a murine model of AIDS. Acta Haematol 92:182-186, 1994.
219. Moqattash S, Lutton JD, Rosenthal G, Abu-Hijleh MF, Abraham NG. Effect of blood substitute, Recombinant Hemoglobin, on in vivo hematopoietic recovery from AZT toxicity. Acta Haematol 98:76-82, 1997.
220. Castello G, Mela G, Cerruti A, Mencoboni M, Lerza R. Azidothymidine and INF-α in vitro effects on hematopoiesis: Protective in vitro activity of IL-1 and GM-CSF. Exp Hematol 23:1367-1371, 1995.
221. Bhalla K, Birkhofer M, Grant S, Graham G. The effect of human recombinant GM-CSF on 3-azido-3-deoxythymidine(AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells. Exp Hematol 17:17-20, 1989.
222. Abraham NG, Chertkov GL, Staudinger, Jiang S, Lutton JD, Argani I, Levere RD, Cappas A. Long-term bone marrow stromal and hemopoietic toxicity to AZT: Protective role of heme and IL-1. Exp Hematol 21:263-268, 1993.
223. Lutton JD, Cherkov JL, Jiang S, Kappas A, Levere RD, Abraham NG. Synergistic recovery of hematopoietic stromal regeneration by heme and interleukin-1 after radiation damage. Am J Hematol 44:172-178, 1993.
224. Abraham NG, Drummond G, Kappas A, Lutton JD. The significance and physiological role of heme oxygenase. Cell Physiol Biochem 6:129-168, 1996.
225. Lutton JD, Chertkov JL, Levere RD, Abraham NG. Comparative effects of heme analogs on hematopoiesis in lymphoproliferative disorders. Leuk Lymphoma 5:179-185, 1991.
226. Abraham NG, Levere RD, Lutton JD. Eclectic mechanisms of heme regulation of hematopoiesis. Int J Cell Cloning 9:185-210, 1991.
227. Abraham NG, Friedland ML, Levere RD. Heme metabolism in hepatic and erythroid cells. In: Brown E, Ed. Progress in Hematology, Vol. XIII. New York: Grune & Stratton, pp75-130, 1983.
228. Lutton JD, Abraham NG. Physiological role of heme and cytochrome P450 in hematopoietic cells. Proc Soc Exp Biol Med 196:260-269, 1991.
229. Lutton JD, da Silva J-L, Moqattash S, Brown AC, Abraham NG. Differential induction of hemeoxygenase in the hepatocarcinoma cell line Hep3B by environmental agents. J Cell Biochem 49:1-7, 1992.
230. Weiss G, Lutton JD, Fuchs D, Werner-Felmayer G, Bock G, Dierich MP, Watcher H. Comparative effects of heme and metalloporphyrins on interferon-γ-mediated pathways in monocytic cells. Proc Soc Exp Biol Med 202:470-475, 1993.
231. Abraham NG, Konwalinka G, Lutton JD, Levere RD, Griffin MO, Shibahara S. Heme modulation of the microenvironment in the regulation of bone marrow growth and differentiation. In: Sachs L, Abraham NG, Wiedermann C, Levine AS, Konwalinka G, Eds. Molecular Biology of Hematopoiesis. Andover, Hampshire, UK: Intercept, Ltd., pp267-278, 1990.
232. Novogrodsky A, Suthantheran M, Stenzel KH. Immune stimulatory properties of metalloporphyrins. J Immunol 143:3981-3987, 1989.
233. Wagener TATG, Feldman E, de Witte T, Abraham NG. Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cells. Proc Soc Exp Biol Med 216:455-463, 1997.